Dr. Suresh Kumar Srinivasan, MD

Dr. Srinivasan practices at Trinity Health System in Steubenville, Ohio, part of University of Pittsburgh Medical Center.

Dr. Srinivasan's NPI, 1346672268, was assigned on August 1, 2013. Dr. Srinivasan holds Ohio license 35.135171.

Dr. Srinivasan's primary practice is Trinity Health System, at 380 Summit Avenue, Steubenville, OH 43952 in Jefferson County. The practice phone is (740) 264-7212. Dr. Srinivasan also practices at Trinity Medical Center West, 4000 Johnson Rd, Steubenville, OH 43952.

Dr. Srinivasan's primary practice is Trinity Health System in Steubenville, Ohio, part of University of Pittsburgh Medical Center. Dr. Srinivasan is also affiliated with Weirton Medical Center. The medical group on file is Trinity Family Care Centers. Dmand AI also links Dr. Srinivasan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Srinivasan practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Srinivasan's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dmand AI has Dr. Srinivasan's licenses on file in 2 states: Ohio and Pennsylvania.

CMS data shows 2,694 Medicare services from Dr. Srinivasan across 17 procedure codes in 2024, for 358 Medicare patients. Medicare paid $90,957 for them.

CMS counts 358 Medicare patients who saw Dr. Srinivasan in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have arthritis, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Srinivasan's median patient age at 69, with 64% women.

In 2024, Dr. Srinivasan wrote 4,069 Medicare Part D claims for 589 patients. 93% of them were for generic drugs. CMS names the drug for 3,976 of them, across 31 drugs with 11 or more claims each, at $289,530 in total drug cost. In 2023, CMS named 4,335 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Srinivasan for performance year 2024, reported as part of a group. Dr. Srinivasan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Srinivasan, published from 2014 to 2024. 2023 was the busiest year, with 3. Dr. Srinivasan has published most often in Cureus. Dr. Srinivasan's most frequent co-authors are Sanjeet Narang, MD, Nantthasorn Zinboonyahgoon, MD and Suchit Khanduja, MD.

CMS Open Payments shows 388 general payments to Dr. Srinivasan from 33 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 62% of the total. Abbott Laboratories paid the most, $4,998.